Medical Device Link.

Founded in 1988, AngioDynamics Inc. (Queensbury, NY) has grown into a Nasdaq-listed public company with 565 employees and a total market capitalization of more than $300 million. The company's position as a broad-based player focused specifically on peripheral interventional devices and interventional oncology makes it unique among its competitors. In this issue's cover story, Eamonn P. Hobbs, president and CEO of AngioDynamics, discusses the company's strategic market focus and its plans for continued growth.

Sustaining Financial Strength | Oncology's Cutting Edge

Industry's IP leaders maintain dominance through incremental portfolio improvements.

Shifting standards and market pressures are driving connectivity among medical devices and healthcare information technologies.

Integration and Interoperable Systems | The Handheld Interface | Alternate-Site and Home-Use IT | Wearable and Implantable IT | Imaging Information and PACS

To protect their companies, medtech leaders should keep an eye on six factors influencing liability coverage and availability.

When medtech companies of similar size merge, company executives need to work extra hard to identify and balance potential IP risks.

Looming transparency legislation would create significant administrative burdens and liability exposure for medical device manufacturers.

Medtech marketers are challenged to develop consistent messages for distribution through ever-changing media.